Cancer Drug Thalomid (thalidomide) can Cause Serious Side Effects, Including Secondary Cancers
Thalomid May Cause Serious Side Effects. Thalomid (thalidomide) capsules are used to treat multiple myeloma, which is a cancer of the plasma cells; these are a type of white blood cell that helps the immune system protect the body against germs and other harmful substances. But while Thalomid is supposed to treat cancer, it … [Read more...]
Thalidomide Increases Risk of Second Primary Malignancies
Thalidomide Risk of Second Primary Malignancies. The (U.K.) Medicines and Healthcare Regulatory Agency (MHRA) has issued a warning of the risk of developing a second primary malignancy for patients taking thalidomide to treat cancer. Health Canada has issued a similar warning. Thalidomide is licensed in the U.K., … [Read more...]
Compensation Payments Increased for 455 Surviving Victims of Thalidomide
Compensation Payments For Thalomide Victims. After being developed in Germany in 1953, thalidomide was originally marketed in 1957 as a “wonder drug” for insomnia, colds, coughs, and headaches. It was then promoted as a sedative to treat morning sickness in pregnant women and was licensed in the UK in 1958. The drug … [Read more...]
